Looking to Brilacidin, the lead drug candidate in the Company’s definsin-mimetic platform, Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection
Why can't they say the name of the Pharma Company? That would make a HUGE Difference in the PR
Market Data 
Markets 
AI
